An international research team led by Prof. Dr. Sedat Nizamoğlu from the Department of Electrical and Electronics Engineering ...

New research finds that retinal diseases thought to map one-to-one to genetic mutations are more complicated than that.

Dr Sunir Garg reflects on the recent American Academy of Ophthalmology meeting in Orlando and expresses excitement on how artificial intelligence (AI) can be used to detect, treat, and transform the ...

The Korea Research Institute of Standards and Science (KRISS) has developed a retina-mimicking eye phantom that faithfully replicates the structural layers and microvascular network of the human ...

Every last Sunday of September marks World Retinitis Pigmentosa (RP) Day, a day dedicated to raising awareness and accelerating efforts to find a cure for this rare, inherited retinal disease ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.

Golgi Neurosciences srl and Breye Therapeutics ApS have established a collaboration to develop Golgi’s P2X7 receptor antagonist program for retinal disorders. The companies have now closed the ...

Population-based studies have shown retinal disorders are the most common cause of irreversible blindness in developed countries and the second most common cause of blindness after cataracts in ...

The study showed that nanoparticles injected into the retina can successfully stimulate the visual system and restore vision in mice with retinal diseases. The findings suggest that a new type of ...

In a genetic association study, investigators integrated data from genome-wide association studies of various disorders with retinal transcriptomic data. Findings revealed that the polygenic risk of ...